The U.S. House of Representatives just passed a sweeping reform, called the 21st Century Cures Act, that will infuse $1 billion in new funding earmarked for opioid treatment and prevention services.
It has taken several years of alarming statistics on the national opioid epidemic, but Congress has responded. This USA Today article provides an overview of the numbers. In addition to the $1 billion for opioid services will be another $4.8 billion for cutting-edge research around treating Alzheimers, cancer, traumatic brain injury, and other medical issues.
The bill received enormous bipartisan support and passed 392-to-26. In 2016, death by drug overdose surpassed death by car crashes and gun fatalities. The public outcry for government intervention has been steady. With so many families having been affected by addiction issues, the new funding allowance should open doors for opioid treatment particularly in rural areas where opioid services have been severely lacking.
Methadone remains the #1 medication-assisted treatment option. Buprenorphine medications are; however, making a big impact in the treatment field with a wide variety of buprenorphine-based formulations coming to market. In addition to the familiar suboxone film, are probuphine (a buprenorphine implant), subutex (an uncoated buprenorphine tablet), and bunavail.
Posted in Addiction Treatment, Buprenorphine, Drug Treatment, Medication Assisted Treatment, Methadone Clinics, Methadone Maintenance, Naloxone, Naltrexone, Opiate Treatment, Suboxone
Tagged drug legislation, drug treatment funding, opioid treatment
There are currently well over 1000 methadone clinics in operation across the United States and many more throughout the world. Methadone has been a leading treatment intervention for opioid addiction for more than 40 years. Methadone is an FDA-approved medication and it’s use in treating opioid addiction has been identified by SAMHSA as a best practice, evidence-based treatment approach.
Adding to the legacy of methadone as a successful treatment medium are the hundreds of thousands of individuals who have been able to totally eliminate the severe opioid withdrawal sickness that wrecked their lives. The value of this medical benefit is priceless.
The cost for participating in a methadone program varies from clinic to clinic and in part depends on whether the clinic receives any state funding or accepts Medicaid for payment. Many clinics operate as private practices funded primarily through patient self-payment. Private clinics often offer a substantial discount for patients that pay for a month of services in advance.
Due to methadone’s proven efficacy, many addicted people experience rapid relief from opiate withdrawal and find themselves eating and sleeping more normally, gaining weight, and able to work again. They are able to pursue other goals & responsibilities that had previously become too difficult in their active addiction.
Methadone is a powerful medication that must be taken as prescribed and in conjunction with good counseling. When a patient is willing to embrace medication-assisted treatment and to utilize it properly, recovery can happen. This life restoration process is demonstrated on a daily basis all around the country.
Posted in Addiction Recovery, Buprenorphine, Drug Treatment, Florida Methadone Clinics, Methadone, Methadone Clinics, Methadone Maintenance, Methadone Programs, Methadone Treatment, Suboxone, Suboxone Clinics
Tagged evidenced based practice, medication assisted treatment, methadone benefits
It was announced in June that North Dakota would be receiving its first methadone clinic. North Dakota and Wyoming are the only two states in the U.S. that have yet to provide a methadone treatment program for opioid addiction.
The region has suffered in recent years with an increase in the use of heroin and fentanyl, and with associated opioid overdoses. Kurt Snyder is the Executive Director of the new clinic, Heartview Foundation. Mr. Snyder echoed the research-based evidence showing that medication-assisted treatment for opioid addiction provides superior results to abstinence-only treatment interventions.
In the article linked above from The Jamestown Sun, a local police detective indicated that the addiction problem had recently worsened in North Dakota as a result of the price of drugs dropping.
The Heartview Foundation clinic will also offer buprenorphine and naloxone in addition to methadone thus providing a more complete range of medication assisted therapies. Therapeutic counseling and mental health treatment will be a component of the Heartview program as well as drug testing.
Of particular benefit too is the recent initiative in North Dakota that will allow pharmacists the ability to prescribe naloxone so that opioid overdoses can hopefully be greatly reduced. The ready accessibility of naloxone is receiving a nationwide push as communities struggle to address overdose concerns.
Methadone.US welcomes a new addition to the featured clinics here on the site with the listing of BrookStone Medical Center in St. George, Utah.
Posted in Addiction Treatment, Buprenorphine, Drug Rehab Programs, Drug Treatment, Methadone, Methadone Clinics, Methadone Maintenance, Suboxone, Suboxone Doctors
Tagged Kurt Snyder, medication assisted treatment, methadone clinic north dakota, north dakota
The FDA has approved a new implantable drug called Probuphine. Probuphine contains the partial opioid agonist, buprenorphine, which is used to suppress the opioid withdrawal symptoms that interfere with daily life.
The implant is the size of a matchstick and is inserted under the skin in the forearm area. It steadily releases a dose of buprenorphine which has been scientifically proven an effective treatment for eliminating opiate withdrawal symptoms in a number of people physically dependent on opioids.
With heroin and opioid overdose deaths at an all time high in the United States, this new alternative offers one more beneficial path for anyone struggling with opioid relapse and chronic withdrawal. Importantly, Probuphine only treats the physical withdrawal from opioids such that the underlying psychological factors of addiction must still be treated through counseling and other support approaches.
The Wall Street Journal has an extensive article on this new medication and the historically important role of methadone and oral buprenorphine. In the article, Nora Volkow (director of the National Institute on Drug Abuse) is quoted as saying:
Scientific evidence suggests that maintenance treatment with these medications in the context of behavioral treatment and recovery support are more effective in the treatment of opioid-use disorder than short-term detoxification programs aimed at abstinence.
Over 47,000 people died in the U.S. of drug overdoses in 2014. A majority of these were attributed to heroin and prescription painkillers. With continued coverage in the media and ongoing community discussion, more answers and helpful interventions will hopefully see the light of day.
Methadone Information | Suboxone Information
A study by the government agency SAMHSA indicated there were approximately 254,000 patients receiving methadone for opioid addiction in 2006. In 2015, it is most likely that number is much higher given the prevalence of opioid addiction and the continued expansion of outpatient opioid treatment services in the United States. Today, there are considerably more methadone clinics and suboxone-approved physicians than there were a decade ago.
Making a new start with medication-assisted treatment is what hundreds of people across the country are deciding to do for themselves every week. Addiction is a progressive illness – one in which a person’s ability to choose is severely compromised. Medication-assisted treatment using either methadone or buprenorphine (suboxone) provides an important open door to a more responsible, quality life.
A majority of individuals suffering with opioid addiction (particularly when the illness spans years) have experienced dramatic brain changes which deepened their physiological dependency on opiates. This physical dependency is not easily removed. It is severe and persistent thus leading the person to do whatever is necessary to avoid being sick from opioid withdrawal.
Most long-term addicted individuals will tell you they rarely, if ever, get high from the illicit substances they use. They are simply trying to avoid being sick from debilitating opioid withdrawal symptoms. When a patient chooses to receive methadone or buprenorphine under the supervision of a doctor, they are making a decision to face their illness and to do something constructive about it.
As a family or friend, it is very helpful to gain an understanding of addiction and how medication-assisted treatment can be life changing for a person stuck in the cycle of opiate addiction.
Making a new start can be a bit frightening. Will methadone work for me? Will my loved ones condemn me? What about my job, or my legal situation? It becomes easy to put off making a decision when so many questions come into play.
It is important to remember that the road to recovery begins with just one step forward. That step will lead to another and another. This new start is always available. The message is one of hope and opportunity. Opiate addiction is a treatable illness. Medication-assistance can make a real difference.
Posted in Addiction Treatment, Drug Treatment, Medication Assisted Treatment, Methadone, Methadone Clinics, Methadone Maintenance, Methadone Programs, Methadone Success, Methadone Treatment, Opiate Treatment, Recovery, Suboxone, Suboxone Doctors, Suboxone Physicians
Tagged MAT, medication-assistance, medication-assisted treatment